Three young UKE researchers scoop Dr. Martini Prize

16 February 2024
EUR 10,000 in prize money from Germany's oldest medical award

Three young scientists at the University Hospital Hamburg-Eppendorf (UKE) won Monday (February 12, 2024) the Dr. Martini prize, Germany's oldest medical award and which is worth EUR 10,000, for their research into cancer, liver and bone marrow diseases. 

Young scientists advancing medical care 

"The award-winning young scientists show us impressively how cutting-edge research at UKE sharpens our understanding of disease progression, diagnostics and therapy," said Katharina Fegebank, Senator for Science, Research and Equality. That makes a lasting contribution to medical care far beyond Hamburg. Dr. Joseph Tintelnot won first prize for his research into the functioning of tumor cells and for developing a new treatment for pancreatic cancer. Second prize went to Dr. Britta Zecher for her research into immune cell activation in primary sclerosing cholangitis (PSC) - a  long-term progressive disease of the liver and gallbladder. Third prize went to Dr. Nico Gagelmann, who is researching risk factors and treatment of allogeneic stem cell transplants in myelofibrosis, which is a rare bone marrow blood cancer.

Prize presented since 1880

The Dr. Martini Prize is funded by the Helmut and Hannelore Greve Foundation for Science, Development and Culture. Named after the surgeon Dr. Erich Martini, the award boosts talented young doctors and medical researchers in Hamburg. Launched in 1880, the prize was initially funded by doctors and merchants in the city. The award is now presented annually.


Sources and further information

Similar articles

UKE gets EUR 3.7 million for cutting-edge research

European Research Council providing ERC grants

UKE's new prostate cancer centre to launch in 2024

UKE to open newly built Martini Clinic featuring outpatient chemotherapy and eight operating theatres

UKE managing international "GUIDE.MRD" research into cancer

Consortium researching use of liquid biopsies against residual tumor cells - EUR 3.4 million for UKE

AI's impact on medicine

SERIES (4): Alexander T. El Gammal working on an AI-based clinical assistant - portrait of a medical visionary
The Consent Management Platform ( we use could not be loaded. This can happen if AdBlockers incorrectly block this URL. Some features such as maps, proximity search or forms, cannot be used this way. To use these features, please deactivate your AdBlocker or allow access to *